Back to AMLX
BlackRock, Inc. AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
53
Latest value
$303
Q3 2026
Peak value
$153.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $3.2M |
| Q4 2025 | $399K |
| Q4 2025 | $3.8M |
| Q4 2025 | $7.1M |
| Q4 2025 | $53.8M |
| Q4 2025 | $36.5M |
| Q4 2025 | $114K |
| Q4 2025 | $179K |
| Q4 2025 | $488K |
| Q4 2025 | $3.4M |
| Q4 2025 | $179K |
| Q4 2025 | $241K |
| Q1 2026 | $2.2M |
| Q1 2026 | $439K |
| Q1 2026 | $4.1M |
| Q1 2026 | $7.2M |
| Q1 2026 | $62.7M |
| Q1 2026 | $40.7M |
| Q1 2026 | $43K |
| Q1 2026 | $136K |
| Q1 2026 | $4K |
| Q1 2026 | $4.3M |
| Q1 2026 | $206K |
| Q1 2026 | $639K |
| Q1 2026 | $136 |
| Q2 2026 | $3.2M |
| Q2 2026 | $627K |
| Q2 2026 | $5.1M |
| Q2 2026 | $10.7M |
| Q2 2026 | $81.2M |
| Q2 2026 | $53.2M |
| Q2 2026 | $55K |
| Q2 2026 | $270K |
| Q2 2026 | $242K |
| Q2 2026 | $3.1M |
| Q2 2026 | $266K |
| Q2 2026 | $577K |
| Q2 2026 | $175 |
| Q3 2026 | $7.4M |
| Q3 2026 | $9K |
| Q3 2026 | $533K |
| Q3 2026 | $9M |
| Q3 2026 | $19.8M |
| Q3 2026 | $153.4M |
| Q3 2026 | $100.9M |
| Q3 2026 | $158K |
| Q3 2026 | $203K |
| Q3 2026 | $1.8M |
| Q3 2026 | $467K |
| Q3 2026 | $5.8M |
| Q3 2026 | $336K |
| Q3 2026 | $1.9M |
| Q3 2026 | $303 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $303 | 10 | — | — |
| Q3 2026 | $1.9M | 65.2K | — | — |
| Q3 2026 | $336K | 11.5K | — | — |
| Q3 2026 | $5.8M | 199.8K | — | — |
| Q3 2026 | $467K | 16.1K | — | — |
| Q3 2026 | $1.8M | 63.5K | — | — |
| Q3 2026 | $203K | 7.0K | — | — |
| Q3 2026 | $158K | 5.4K | — | — |
| Q3 2026 | $100.9M | 3.47M | — | — |
| Q3 2026 | $153.4M | 5.27M | — | — |
| Q3 2026 | $19.8M | 679.0K | — | — |
| Q3 2026 | $9M | 310.1K | — | — |
| Q3 2026 | $533K | 18.3K | — | — |
| Q3 2026 | $9K | 316 | — | — |
| Q3 2026 | $7.4M | 253.2K | — | — |
| Q2 2026 | $175 | 10 | — | — |
| Q2 2026 | $577K | 32.1K | — | — |
| Q2 2026 | $266K | 14.8K | — | — |
| Q2 2026 | $3.1M | 170.3K | — | — |
| Q2 2026 | $242K | 13.5K | — | — |
| Q2 2026 | $270K | 15.0K | — | — |
| Q2 2026 | $55K | 3.1K | — | — |
| Q2 2026 | $53.2M | 2.96M | — | — |
| Q2 2026 | $81.2M | 4.52M | — | — |
| Q2 2026 | $10.7M | 597.0K | — | — |
| Q2 2026 | $5.1M | 283.5K | — | — |
| Q2 2026 | $627K | 34.9K | — | — |
| Q2 2026 | $3.2M | 178.8K | — | — |
| Q1 2026 | $136 | 10 | — | — |
| Q1 2026 | $639K | 45.9K | — | — |
| Q1 2026 | $206K | 14.8K | — | — |
| Q1 2026 | $4.3M | 306.7K | — | — |
| Q1 2026 | $4K | 258 | — | — |
| Q1 2026 | $136K | 9.8K | — | — |
| Q1 2026 | $43K | 3.1K | — | — |
| Q1 2026 | $40.7M | 2.93M | — | — |
| Q1 2026 | $62.7M | 4.51M | — | — |
| Q1 2026 | $7.2M | 520.3K | — | — |
| Q1 2026 | $4.1M | 297.1K | — | — |
| Q1 2026 | $439K | 31.6K | — | — |
| Q1 2026 | $2.2M | 159.9K | — | — |
| Q4 2025 | $241K | 19.9K | — | — |
| Q4 2025 | $179K | 14.8K | — | — |
| Q4 2025 | $3.4M | 278.7K | — | — |
| Q4 2025 | $488K | 40.4K | — | — |
| Q4 2025 | $179K | 14.8K | — | — |
| Q4 2025 | $114K | 9.4K | — | — |
| Q4 2025 | $36.5M | 3.02M | — | — |
| Q4 2025 | $53.8M | 4.46M | — | — |
| Q4 2025 | $7.1M | 585.9K | — | — |
| Q4 2025 | $3.8M | 314.1K | — | — |
| Q4 2025 | $399K | 33.1K | — | — |
| Q4 2025 | $3.2M | 267.4K | — | — |
Other funds holding AMLX
$460.9M
$307.7M
$261.7M
$201.3M
$174.7M
$153.5M